Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2025-12-26 @ 1:30 AM
Study NCT ID:
NCT00195533
Status:
COMPLETED
Last Update Posted:
2009-11-16
First Post:
2005-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-07
Start Date Type:
None
Primary Completion Date:
2005-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-13
First Submit QC Date:
None
Study First Post Date:
2005-09-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-11-13
Last Update Post Date:
2009-11-16
Last Update Post Date Type:
ESTIMATED